Rubenstein David M. sold $17.1M of CG

Rubenstein David M. sold 400,000 shares of Carlyle Group Inc. (CG) at $42.74 ($17.10M total) on 2026-09-11.

Original reporting
SEC EDGAR · Rubenstein David M.
Published Sep 11, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 9:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CG
Neutral
medium confidence
Mentioned
$CG
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CGNeutralLow
01

Why it matters

Traders may monitor whether this is part of a broader pattern of insider selling, but the filing alone does not change earnings power, capital allocation, or regulatory outlook.

02

Market read

A director open-market sale of about $17.1M is disclosed, which can slightly affect sentiment but is unlikely to be a standalone driver of price.

03

What to watch

No 10b5-1 plan is disclosed here, but the article also provides no reason for the sale, and the holdings after sale remain very large, reducing the inference of distress.

Relevance 7/10Novelty 4/10Timing: filed 2026-09-11, transaction dated 2026-09-11

Background

The article is an SEC Form 4 insider transaction disclosure for Carlyle Group Inc. (CG).

Company-level read

Ticker impact

$CGNeutralMedium confidence
Context

Carlyle Group director David M. Rubenstein sold 400,000 shares on 2026-09-11 at $42.74 for about $17.1M, per Form 4.

Expected impact

Likely limited near-term impact; any effect would be short-lived unless paired with broader insider selling trends or company-specific news.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no stated company event; such sales typically do not drive sustained repricing by themselves.

Market effects

Minimal. Insider sales at a single alternative-asset manager do not materially change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Director sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be noise rather than bearish information.

Key entities

  • Carlyle Group Inc.

    Alternative asset manager subject of the Form 4 insider sale.

  • David M. Rubenstein

    Director who sold 400,000 shares on 2026-09-11.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CGMed

Evercore ISI cuts Carlyle Group stock price target on fee concerns

Evercore ISI reduced its price target for The Carlyle Group (CG) to $42 from $43, citing lower fee-related revenue expectations. The firm cut its 2027 and 2028 EPS estimates by 3.1% and 3.3%, respectively. Carlyle's Q3 2026 earnings beat estimates, but its stock has fallen 31% year-to-date. The company aims for $200B in fundraising and 15% fee-earnings growth through 2028.

$CGMedAI 8/10

Carlyle’s third-quarter profit beats estimates on pick-up in asset sales

Carlyle Group reported third-quarter profit above estimates, driven by asset sales and returning $100B to investors in 2024. Distributable earnings were $1.12 per share, beating analyst expectations. Realized net performance revenue surged to $99.8M. The company expects strong monetization and $20B inflows in Q4. Shares fell 7% amid broader market sell-off, down 28% YTD.

$CGHighAI 8/10

The Carlyle Group Inc (CG) (Q3 2026) Earnings Call Highlights: Record FRE and $479 Billion

The Carlyle Group (CG) reported Q3 2026 earnings with distributable earnings per share up 17% YoY to $1.12. AUM reached $479 billion, with $28 billion in pending fee-earning AUM. Net realized performance revenues increased fivefold YoY. The company returned $24 billion to clients in the past year. However, higher interest rates impacted fee-paying AUM in the credit segment, and transaction fees were lighter. The firm expects mid-single-digit fee-related earnings growth for 2026.

$CGMedAI 8/10

Carlyle (CG) Q3 2026 Earnings Call Transcript

Carlyle Group (CG) reported Q3 2026 earnings, highlighting strong economic indicators, with portfolio company revenues growing 6% and EBITDA up double-digits. The firm returned $24 billion to clients in private equity and saw $7 billion in global credit inflows. Distributable earnings rose 17% year-over-year to $433 million. Carlyle expects record full-year fee-related earnings and strong Q4 inflows, with total AUM at $479 billion.

$CGMedAI 8/10

What Carlyle Group (CG) Said on Its Q3 Earnings Call

Carlyle Group reported Q3 assets under management at $479B, with pending fee-earning assets up 50% YoY. Management expects $230M in annualized fees from these assets. Net realized performance revenue was $100M, five times higher than last year. Global Private Equity returned $24B to clients over 12 months. Carlyle declared a $0.35 quarterly dividend and repurchased 15M shares YTD.